- Home
- MYSZ vs SONN Comparison
MYSZ vs SONN Comparison
Compare MYSZ & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYSZ
- SONN
- Stock Information
- Founded
- MYSZ 1999
- SONN N/A
- Country
- MYSZ Israel
- SONN United States
- Employees
- MYSZ N/A
- SONN N/A
- Industry
- MYSZ Computer Software: Prepackaged Software
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- MYSZ Technology
- SONN Health Care
- Exchange
- MYSZ Nasdaq
- SONN Nasdaq
- Market Cap
- MYSZ 2.5M
- SONN 2.5M
- IPO Year
- MYSZ N/A
- SONN N/A
- Fundamental
- Price
- MYSZ $1.33
- SONN $1.31
- Analyst Decision
- MYSZ Strong Buy
- SONN Strong Buy
- Analyst Count
- MYSZ 1
- SONN 2
- Target Price
- MYSZ $3.00
- SONN $38.00
- AVG Volume (30 Days)
- MYSZ 3.6M
- SONN 37.4K
- Earning Date
- MYSZ 05-14-2025
- SONN 05-13-2025
- Dividend Yield
- MYSZ N/A
- SONN N/A
- EPS Growth
- MYSZ N/A
- SONN N/A
- EPS
- MYSZ N/A
- SONN N/A
- Revenue
- MYSZ $8,257,000.00
- SONN $1,000,000.00
- Revenue This Year
- MYSZ $35.62
- SONN N/A
- Revenue Next Year
- MYSZ $12.88
- SONN N/A
- P/E Ratio
- MYSZ N/A
- SONN N/A
- Revenue Growth
- MYSZ 18.02
- SONN 674.14
- 52 Week Low
- MYSZ $1.05
- SONN $1.22
- 52 Week High
- MYSZ $9.40
- SONN $16.80
- Technical
- Relative Strength Index (RSI)
- MYSZ 45.43
- SONN 39.74
- Support Level
- MYSZ $1.18
- SONN $1.33
- Resistance Level
- MYSZ $3.04
- SONN $1.35
- Average True Range (ATR)
- MYSZ 0.24
- SONN 0.09
- MACD
- MYSZ 0.04
- SONN -0.00
- Stochastic Oscillator
- MYSZ 8.02
- SONN 36.00
About MYSZ My Size Inc.
My Size Inc is a USA based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers, and licensing cloud-enabled software subscriptions, associated software maintenance and support.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.